Health Economics of Pharmaceuticals - Adipositas MV

Health Economics of Pharmaceuticals - Adipositas MV

The Lancet, Early Online Publication,

4 February 2011 doi:10.1016/S0140-6736(10)62037


National, regional, and global trends in body-mass index

since 1980: systematic analysis of health examination

surveys and epidemiological studies with 960 country-

years and 9·19

1 million participants

Mariel M Finucane AB a *, Gretchen A Stevens DSc e *,

Melanie J Cowan MPH f, Goodarz Danaei MD b, John K Lin

AB c, Christopher J Paciorek PhD g, Gitanjali M Singh PhD c,

Hialy R Gutierrez BS h, Yuan Lu MSc c, Adil N Bahalim

MEng h, Farshad Farzadfar MD c, Leanne M Riley MSc f, , Prof

Majid Ezzati PhD c d i j , on behalf of the Global Burden of

Metabolic Risk Factors of Chronic Diseases Collaborating

Group (Body Mass Index)†

Weitere Magazine dieses Users
Ähnliche Magazine